eprintid: 95691
rev_number: 3
eprint_status: archive
dir: disk0/00/09/56/91
datestamp: 2026-06-19 04:54:39
lastmod: 2026-06-19 04:54:39
status_changed: 2026-06-19 04:54:39
type: article
metadata_visibility: show
creators_name: Jumayev M. Yu, Jumayev M. Yu
creators_name: Xayitova G. A, Xayitova G. A
creators_name: Xalilova  X. A, Xalilova  X. A
title: SUT BEZI SARATONI KASALLIGINI KIMYOTERAPIYA BILAN DAVOLASHNING YUTUQ VA KAMCHILIKLARI
ispublished: pub
keywords: sut bezi saratoni, kimyoterapiya, doksorubitsin, paklitaksel, neoadjuvant terapiya, toksiklik, umumiy omon qolish.
abstract: Sut bezi saratoni (SBS) ayollar orasida eng ko‘p uchraydigan onkologik kasallik bo‘lib, global o‘lim sabablaridan biri hisoblanadi. Kimyoterapiya kasallikning erta va rivojlangan bosqichlarida muhim davolash usuli sifatida qo‘llaniladi. Ayniqsa, antrasiklinlar, taksanlar va platina asosidagi preparatlar adjuvant, neoadjuvant hamda metastatik bosqichlarda samarali hisoblanadi. Ushbu maqolada kimyoterapiyaning klinik samaradorligi, omon qolish ko‘rsatkichlariga ta’siri hamda nojo‘ya ta’sirlari tahlil qilinadi.
date: 2026-03-29
official_url: https://universalconference.us/index.php/icast/article/view/6903
full_text_status: public
publication: INTERNATIONAL CONFERENCE ON ADVANCE SCIENCE AND TECHNOLOGY
volume: 3
number: 2
pagerange: 53-55
citation:   Jumayev M. Yu, Jumayev M. Yu, Xayitova G. A, Xayitova G. A, Xalilova X. A, Xalilova X. A  (2026) SUT BEZI SARATONI KASALLIGINI KIMYOTERAPIYA BILAN DAVOLASHNING YUTUQ VA KAMCHILIKLARI.  INTERNATIONAL CONFERENCE ON ADVANCE SCIENCE AND TECHNOLOGY, 3 (2).  pp. 53-55.      
document_url: https://arxiv.universalpublishings.com/id/eprint/95691/1/53-55.pdf